Calpain, BDNF/TrkB, and Offspring Cognition
2026-09-08
A 2025 Neuropharmacology study identifies excessive calpain activation as a mechanistic link between maternal non-obstetric surgery during pregnancy and later cognitive impairment in rat offspring. Pharmacological rescue with MDL 28170 or a TrkB agonist connected protease activity with hippocampal BDNF/TrkB signaling, synaptic structure, and behavioral outcomes.
5-EdU Maps Cell-Cycle Dynamics in CNS Repair
2026-09-08
5-Ethynyl-2'-deoxyuridine (5-EdU) converts DNA synthesis into a sensitive, spatially resolved readout for cell proliferation assays. This article shows how to apply the chemistry to astrocyte–microglia communication and tissue regeneration studies without confusing S-phase entry with functional repair.
Phenacetin in hiPSC Intestinal Organoid PK Models
2026-09-07
A translational strategy for using Phenacetin and N-(4-ethoxyphenyl)acetamide in human pluripotent stem cell-derived intestinal organoids, with emphasis on mechanistic interpretation, assay design, solubility, safety boundaries, and pharmacokinetic studies.
TBST (Tris-Buffered Saline and Tween 20) Guide
2026-09-05
TBST (Tris-Buffered Saline and Tween 20), SKU K1199, is a ready-to-use buffered detergent solution for blocking, antibody dilution, and washing in Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. It can reduce nonspecific binding and background, but requires validation in workflows involving detergent-sensitive epitopes, tissues, reporters, or assay chemistries.
Arsenic Neurotoxicity, BBB Disruption, and MMP-2/MMP-9
2026-09-05
This study links sodium arsenite-induced cognitive impairment in male mice to MMP-2/MMP-9-associated blood–brain barrier disruption, tight-junction loss, and hippocampal neuronal apoptosis. Its doxycycline intervention provides pharmacological evidence that MMP activity is a modifiable component of arsenic neurotoxicity, while also leaving important questions about pathway specificity and translation to human exposure.
Erastin B1524: Reproducible Ferroptosis Workflows
2026-09-04
This scenario-driven guide explains how Erastin (SKU B1524) can support reproducible ferroptosis research, from cell-viability assay design to solution handling and vendor selection. It connects practical laboratory decisions with mechanistic evidence on system Xc⁻, oxidative stress, and tumor-cell vulnerability.
Bortezomib (PS-341) for ERAD and Apoptosis Studies
2026-09-04
Bortezomib (PS-341) provides reversible 20S proteasome inhibition for connecting ER-associated degradation to protein accumulation, apoptosis, and cell-state changes. This workflow-oriented guide combines ERAD degron experiments with oncology-focused dose finding, controls, and troubleshooting.
GSK621: From AMPK Mechanism to AML Strategy
2026-09-03
GSK621 offers a powerful way to connect AMPK target engagement with leukemia-cell metabolism, autophagy, apoptosis, and emerging tumor-macrophage biology. This thought-leadership perspective outlines how translational researchers can use the compound to distinguish pathway activation from disease-relevant phenotype.
NBC19 and NLRP3 Assay Design in Cancer Inflammation
2026-09-03
NBC19 is a nanomolar NLRP3 inflammasome inhibitor for dissecting IL-1β release in cellular models. This article connects stimulus-aware assay design with emerging evidence on circulating giant cancer macrophages while clearly separating established findings from testable hypotheses.
Hoechst 33258 Workflow for Tumor pH Studies
2026-09-02
Use Hoechst 33258 as a practical nuclear readout alongside lactate, pH, viability, and immune assays in tumor microenvironment research. Its cell permeability, blue fluorescence, and compatibility with live and fixed samples make it useful for connecting metabolic treatment responses to DNA content, nuclear morphology, and cell-cycle changes.
Tariquidar and the Mechanical Biology of Chemoresistance
2026-09-02
Tariquidar (XR9576) can help translational researchers distinguish mechanically induced P-glycoprotein expression from transporter-driven drug efflux. This thought-leadership analysis connects tumor fluid viscosity, TRPV4–YAP mechanotransduction, and ABC transporter inhibition to practical study design and translational decision-making.
Fludarabine: From DNA Stress to Immune Leverage
2026-09-01
Fludarabine is more than a DNA synthesis inhibitor: it is a mechanistically tractable tool for connecting replication stress, apoptosis, and lymphodepletion to next-generation cancer immunotherapy research.
ICG001: Precision Control of Wnt/β-Catenin
2026-08-31
ICG001 offers translational researchers a way to interrogate Wnt biology at the CBP/β-catenin interface rather than treating the pathway as a single binary switch. This article connects mechanistic insight from osteogenesis research with experimental strategy for cancer, fibrosis, EMT, and stem-cell models.
MMP7, EMT, and β-Catenin in Biliary Atresia
2026-08-31
The 2026 reference study identifies MMP7 as a mechanistic driver of biliary atresia-associated liver fibrosis, linking E-cadherin cleavage with β-catenin nuclear translocation and epithelial–mesenchymal transition. Its integration of patient samples, bioinformatics, biliary epithelial cell experiments, and a chronic mouse model supports MMP7 blockade as an antifibrotic strategy while clarifying how β-catenin pathway modulation could be investigated in follow-up studies.
Cyanidin Chloride: Identity-to-Assay Framework
2026-08-30
Cyanidin Chloride is an anthocyanin polyphenolic antioxidant suited to controlled oxidative stress research. This guide explains how chemical identity, assay architecture, and barrier-function endpoints determine the strength and limits of cellular protection claims.
462 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page